All Stories

  1. MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer

    Article • Cancer Biology & Therapy, March 2019, Taylor & Francis

    HAMID ABDOLMALEKY

  2. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, November 2018, Wiley

    HAMID ABDOLMALEKY

  3. Microbiome, inflammation, epigenetic alterations, and mental diseases

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, July 2017, Wiley

    HAMID ABDOLMALEKY

  4. Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression ofAKT1and key dopaminergic genes

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, October 2016, Wiley

    HAMID ABDOLMALEKY

  5. Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia

    Article • PLOS One, January 2016, PLOS

    HAMID ABDOLMALEKY

  6. Antipsychotic drugs attenuate aberrant DNA methylation ofDTNBP1(dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, August 2015, Wiley

    HAMID ABDOLMALEKY

  7. An update on the epigenetics of psychotic diseases and autism

    Article • Epigenomics, June 2015, Future Medicine

    HAMID ABDOLMALEKY

  8. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia

    Article • Schizophrenia Research, February 2014, Elsevier

    HAMID ABDOLMALEKY

  9. Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis?

    Article • Epigenomics, December 2011, Future Medicine

    HAMID ABDOLMALEKY

  10. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder

    Article • Journal of Psychiatric Research, November 2011, Elsevier

    HAMID ABDOLMALEKY

  11. Emerging roles of epigenetic mechanisms in Parkinson’s disease

    Article • Functional & Integrative Genomics, September 2011, Springer Science + Business Media

    HAMID ABDOLMALEKY

  12. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder

    Article • Schizophrenia Research, July 2011, Elsevier

    HAMID ABDOLMALEKY

  13. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, May 2011, Wiley

    HAMID ABDOLMALEKY

  14. Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics

    Article • Pharmacogenomics, December 2008, Future Medicine

    HAMID ABDOLMALEKY

  15. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

    Article • Human Molecular Genetics, September 2006, Oxford University Press (OUP)

    HAMID ABDOLMALEKY

  16. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, April 2005, Wiley

    HAMID ABDOLMALEKY

  17. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia

    Article • Schizophrenia Research, March 2004, Elsevier

    HAMID ABDOLMALEKY

  18. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation

    Article • American Journal of Medical Genetics, January 2004, Wiley

    HAMID ABDOLMALEKY